Cancer Network ... we had our brief golden age from 1996 to 2003 when after a 39-year period where there was nothing but 5-fluorouracil, we had a series of drugs come along— irinotecan , cytoplatin, capecitabine, bevacizumab, cetuximab, and then ultimately panitumumab.
Wall Street Journal (press release) Pexa-Vec is also being evaluated in a Phase 1-2 clinical study in patients with treatment-refractory colorectal cancer as monotherapy and in combination with irinotecan , and in a Phase 2a clinical study in treatment-refractory kidney cancer patients ... and more »
OncLive Patients had been randomly assigned to either FOLFIRI (fluorouracil, leucovorin, and irinotecan ) or mFOLFOX6 (modified fluorouracil, leucovorin, and oxaliplatin) plus cetuximab (n = 59) or one of the two chemotherapy regimens alone (n = 57). Treatment ...
The Pharma Letter If Alchemia's current HA- Irinotecan Phase III clinical trial (NCT01290783) is successful, and the drug obtains health authority approval for use in irinotecan -containing chemotherapy regimens, there is the possibility that HA- Irinotecan will ...
Wall Street Journal (press release) ... The most frequent adverse reactions seen in patients with EGFR-expressing metastatic colorectal cancer (n=354) treated with ERBITUX plus irinotecan in clinical trials (incidence >=50%) were acneiform rash (88%), asthenia/malaise (73%), diarrhea (72 ... and more »
Marketwire (press release) Pexa-Vec is also being evaluated in a Phase 1-2 clinical trial in patients with treatment-refractory colorectal cancer as monotherapy and in combination with irinotecan , and in a Phase 2a clinical trial in treatment-refractory kidney cancer patients ... and more »
